524 related articles for article (PubMed ID: 15500747)
1. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
2. [Development of intraperitoneally transplantated human ovarian carcinoma model with immune reconstruction in severe combined immunodeficient mice].
Zhu H; Ye D; Chen H; Lu W; Xie X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):630-3. PubMed ID: 12133487
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice.
Ye F; Chen H; Liang Z; Lu W; Cheng Q; Xie X
Eur J Gynaecol Oncol; 2006; 27(6):566-72. PubMed ID: 17290584
[TBL] [Abstract][Full Text] [Related]
4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
5. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
Zeng QH; Wang W; Liu T; Shi Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of human retinoblastoma model in human immune reconstruction non-obese diabetic-severe combine immunodeficient mice].
Zhong XF; Ge J; Peng FH; Zhang B; Lin JX; Zhang WX; Li YP
Zhonghua Yan Ke Za Zhi; 2007 Aug; 43(8):739-43. PubMed ID: 18001574
[TBL] [Abstract][Full Text] [Related]
7. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
8. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
[TBL] [Abstract][Full Text] [Related]
9. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes.
Sandhu JS; Gorczynski R; Shpitz B; Gallinger S; Nguyen HP; Hozumi N
Transplantation; 1995 Jul; 60(2):179-84. PubMed ID: 7624960
[TBL] [Abstract][Full Text] [Related]
10. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
[TBL] [Abstract][Full Text] [Related]
11. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
12. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the adoptive transfer of delayed hypersensitivity and T cell repertoire in severe combined immunodeficiency mice reconstituted with human lymphocytes.
Mancia L; Mariani F; Mattei M; Montesano C; Placido R; Colizzi V; Salerno A; Bellavia A
Folia Biol (Praha); 1994; 40(6):411-30. PubMed ID: 7589700
[TBL] [Abstract][Full Text] [Related]
14. Human tonsil implants xenotransplanted in SCID mice display broad lymphocytic diversity and cellular activation profile similar to those in the original lymphoid organ.
Vallet V; Mauray S; Kindler V; Aubry D; Ruegg M; Cherpillod J; Waridel F; Schapira M; Duchosal MA
Xenotransplantation; 2005 Jan; 12(1):38-48. PubMed ID: 15598272
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunomodulators in the hu-PBL-SCID mouse model.
Mead JR; Burger RA; Morrey JD; Warren RP; Okleberry KM; Sidwell RW
Biotechnol Ther; 1993; 4(1-2):133-43. PubMed ID: 8374509
[TBL] [Abstract][Full Text] [Related]
16. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
17. [Reconstitution of Hu-SCID mice transplanted with human tonsillar lymphocytes immunized with dengue virus-2 in vitro and its immune response].
Zuo L; Guo H; Zhang C
Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):597-9. PubMed ID: 9275474
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
[TBL] [Abstract][Full Text] [Related]
19. SCID mouse as a model for transplantation studies.
Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
[TBL] [Abstract][Full Text] [Related]
20. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]